Evidence from other cancers indicates that UBR5 promotes tumor growth by maintaining an immunosuppressive tumor microenvironment and facilitating immune evasion mediated by WNT/β-catenin and PD-L1, among other pathways. Here, UBR5 is linked to cancer.